News
A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
The study supports prior research that found the same thing.
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...
In Australia, Ozempic is approved for the treatment of type 2 diabetes, while Wegovy is approved for weight management. Both ...
11d
New Scientist on MSNDrugs like Ozempic and Wegovy could significantly cut dementia riskDozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...
According to Kiran Jones, a clinical pharmacist at Oxford Online Pharmacy, some of the most concerning side effects of GLP-1 ...
Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
2d
Verywell Health on MSN4 Foods to Avoid and 3 You Should Eat While Taking OzempicCertain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.
Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.
A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results